from 31 Mar 2012 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary: ACCENDRA HEALTH INC/VA/ quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Mar 2012 to 31 Mar 2025.
ACCENDRA HEALTH INC/VA/ Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $35,066,000, a 34% increase year-over-year.
ACCENDRA HEALTH INC/VA/ annual Net Cash Provided by (Used in) Operating Activities for 2024 was $161,495,000, a 78% decline from 2023.
ACCENDRA HEALTH INC/VA/ annual Net Cash Provided by (Used in) Operating Activities for 2023 was $740,710,000, a 128% increase from 2022.
ACCENDRA HEALTH INC/VA/ annual Net Cash Provided by (Used in) Operating Activities for 2022 was $325,006,000, a 162% increase from 2021.
Source SEC data: View on sec.gov

Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)

Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)

Net Cash Provided by (Used in) Operating Activities, Annual (USD)

Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$35,066,000	+$17,896,000	+34%	01 Jan 2025	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q1 2024	$52,962,000	-$211,360,000	-133%	01 Jan 2024	31 Mar 2024	10-Q	08 May 2025	2025	Q1
Q1 2023	$158,398,000	+$78,699,000	+99%	01 Jan 2023	31 Mar 2023	10-Q	03 May 2024	2024	Q1
Q1 2022	$79,699,000	+$54,276,000	+213%	01 Jan 2022	31 Mar 2022	10-Q	05 May 2023	2023	Q1
Q1 2021	$25,423,000	-$68,031,000	-73%	01 Jan 2021	31 Mar 2021	10-Q	04 May 2022	2022	Q1
Q1 2020	$93,454,000	+$154,358,000		01 Jan 2020	31 Mar 2020	10-Q	05 May 2021	2021	Q1
Q1 2019	$60,904,000	-$79,177,000	-433%	01 Jan 2019	31 Mar 2019	10-Q	06 May 2020	2020	Q1
Q1 2018	$18,273,000	+$44,633,000		01 Jan 2018	31 Mar 2018	10-Q	07 May 2019	2019	Q1
Q1 2017	$26,360,000	-$71,505,000	-158%	01 Jan 2017	31 Mar 2017	10-Q	10 May 2018	2018	Q1
Q1 2016	$45,145,000	-$123,558,000	-73%	01 Jan 2016	31 Mar 2016	10-Q	03 May 2017	2017	Q1
Q1 2015	$168,703,000	+$75,501,000	+81%	01 Jan 2015	31 Mar 2015	10-Q	04 May 2016	2016	Q1
Q1 2014	$93,202,000	-$61,409,000	-40%	01 Jan 2014	31 Mar 2014	10-Q	28 Apr 2015	2015	Q1
Q1 2013	$154,611,000	+$52,714,000	+52%	01 Jan 2013	31 Mar 2013	10-Q	01 May 2014	2014	Q1
Q1 2012	$101,897,000			01 Jan 2012	31 Mar 2012	10-Q	03 May 2013	2013	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$161,495,000	-$579,215,000	-78%	01 Jan 2024	31 Dec 2024	10-K	28 Feb 2025	2024	FY
2023	$740,710,000	+$415,704,000	+128%	01 Jan 2023	31 Dec 2023	10-K	28 Feb 2025	2024	FY
2022	$325,006,000	+$200,829,000	+162%	01 Jan 2022	31 Dec 2022	10-K	28 Feb 2025	2024	FY
2021	$124,177,000	-$215,046,000	-63%	01 Jan 2021	31 Dec 2021	10-K	20 Feb 2024	2023	FY
2020	$339,223,000	+$173,138,000	+104%	01 Jan 2020	31 Dec 2020	10-K	28 Feb 2023	2022	FY
2019	$166,085,000	+$50,496,000	+44%	01 Jan 2019	31 Dec 2019	10-K	23 Feb 2022	2021	FY
2018	$115,589,000	+$58,815,000	+104%	01 Jan 2018	31 Dec 2018	10-K	04 Mar 2020	2019	FY
2017	$56,774,000	-$130,921,000	-70%	01 Jan 2017	31 Dec 2017	10-K	06 Mar 2019	2018	FY
2016	$187,695,000	-$82,548,000	-31%	01 Jan 2016	31 Dec 2016	10-K	06 Mar 2019	2018	FY
2015	$270,243,000	+$274,004,000		01 Jan 2015	31 Dec 2015	10-K	23 Feb 2018	2017	FY
2014	$3,761,000	-$144,315,000	-103%	01 Jan 2014	31 Dec 2014	10-K	17 Feb 2017	2016	FY
2013	$140,554,000			01 Jan 2013	31 Dec 2013	10-K	25 Feb 2016	2015	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.